BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17416835)

  • 1. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
    Law M; Young R; Babb J; Pollack E; Johnson G
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.
    Server A; Graff BA; Orheim TE; Schellhorn T; Josefsen R; Gadmar ØB; Nakstad PH
    Neuroradiology; 2011 Jun; 53(6):435-47. PubMed ID: 20857284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.
    Emblem KE; Scheie D; Due-Tonnessen P; Nedregaard B; Nome T; Hald JK; Beiske K; Meling TR; Bjornerud A
    AJNR Am J Neuroradiol; 2008 Oct; 29(9):1664-70. PubMed ID: 18583405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading.
    Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH
    PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.
    Spampinato MV; Schiarelli C; Cianfoni A; Giglio P; Welsh CT; Bisdas S; Rumboldt Z
    Neuroradiol J; 2013 Aug; 26(4):385-95. PubMed ID: 24007727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
    J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements.
    Friedman SN; Bambrough PJ; Kotsarini C; Khandanpour N; Hoggard N
    Br J Radiol; 2012 Dec; 85(1020):e1204-11. PubMed ID: 23175486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.
    Ding B; Ling HW; Chen KM; Jiang H; Zhu YB
    Neuroradiology; 2006 Oct; 48(10):773-81. PubMed ID: 16937146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
    Gahramanov S; Muldoon LL; Li X; Neuwelt EA
    Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors.
    Bulakbasi N; Kocaoglu M; Farzaliyev A; Tayfun C; Ucoz T; Somuncu I
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2187-99. PubMed ID: 16219821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
    Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
    Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.
    Jung SC; Yeom JA; Kim JH; Ryoo I; Kim SC; Shin H; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH; Choi SH
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1103-10. PubMed ID: 24384119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.